| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 20.5M +37.5% | 14.9M +45.9% | 10.2M -26.6% | 13.9M +1.4% | 13.7M |
| R&D | 15.2M +52.4% | 9.9M +60.5% | 6.2M -38.6% | 10.1M +7.4% | 9.4M |
| SG&A | 5.4M +7.8% | 5.0M +23.4% | 4.0M +5.1% | 3.8M -11.6% | 4.3M |
| Operating Income | -20509000 -37.5% | -14912000 -45.9% | -10220000 +26.6% | -13916000 -1.4% | -13722000 |
| EBITDA | -20475000 -37.6% | -14878000 -46.0% | -10189000 +26.6% | -13878000 -1.4% | -13684000 |
| Net Income | -17797000 -34.9% | -13192000 -58.6% | -8316000 +29.5% | -11802000 +4.1% | -12301000 |
| EPS (Basic) | $-0.11 -22.2% | $-0.09 -50.0% | $-0.06 +25.0% | $-0.08 +11.1% | $-0.09 |
| EPS (Diluted) | $-0.11 -22.2% | $-0.09 -50.0% | $-0.06 +25.0% | $-0.08 +11.1% | $-0.09 |
| Shares (Diluted) | 156.6M +7.6% | 145.6M -0.2% | 145.9M +0.6% | 145.1M +11.3% | 130.4M |